RASA1 analysis: Clinical and molecular findings in a series of consecutive cases

European Journal of Medical Genetics

Volumn 55, Issue 2, 2012, Pages 91-95

  Wooderchak Donahue, Whitney ^a   Stevenson, David A ^b   McDonald, Jamie ^b   Grimmer, J Fredrik ^b   Gedge, Friederike ^a   Bayrak Toydemir Pinar, P ^a,b  

^a ARUP INSTITUTE FOR CLINICAL AND EXPERIMENTAL PATHOLOGY   (United States)

^b UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

Arteriovenous fistula (AVF); Arteriovenous malformation (AVM); Capillary malformation; RASA1; Vascular malformation

Indexed keywords

NUCLEAR PROTEIN; RASA1 PROTEIN; UNCLASSIFIED DRUG;

ANGIOOSTEOHYPERTROPHY SYNDROME; ARTERIOVENOUS FISTULA; ARTERIOVENOUS MALFORMATION; ARTICLE; CAPILLARY MALFORMATION ARTERIOVENOUS MALFORMATION SYNDROME; CLINICAL ARTICLE; FEMALE; GENE MUTATION; GENE SEQUENCE; GENETIC ANALYSIS; HUMAN; MACROCEPHALY; MALE; PHENOTYPE; SEIZURE; VEIN OF GALEN MALFORMATION;

ARTERIOVENOUS FISTULA; ARTERIOVENOUS MALFORMATIONS; CAPILLARIES; DATA COLLECTION; HUMANS; KLIPPEL-TRENAUNAY-WEBER SYNDROME; MUTATION; P120 GTPASE ACTIVATING PROTEIN;

FISTULA;

EID: 84857439472     PISSN: 17697212     EISSN: 18780849     Source Type: Journal    
DOI: 10.1016/j.ejmg.2011.11.008     Document Type: Article

References (9)

1. Revencu N., Boon L.M., Mulliken J.B., Enjolras O., Cordisco M.R., Burrows P.E., Clapuyt P., Hammer F., Dubois J., Baselga E., Brancati F., Carder R., Quintal J.M., Dallapiccola B., Fischer G., Frieden I.J., Garzon M., Harper J., Johnson-Patel J., Labrèze C., Martorell L., Paltiel H.J., Pohl A., Prendiville J., Quere I., Siegel D.H., Valente E.M., Van Hagen A., Van Hest L., Vaux K.K., Vicente A., Weibel L., Chitayat D., Vikkula M. Parkes Weber syndrome, vein of Galen aneurysmal malformation, and other fast-flow vascular anomalies are caused by RASA1 mutations. Hum. Mutat. 2008, 29:959-965.
2. Eerola I., Boon L.M., Mulliken J.B., Burrows P.E., Dompmartin A., Watanabe S., Vanwijck R., Vikkula M. Capillary malformation-arteriovenous malformation, a new clinical and genetic disorder caused by RASA1 mutations. Am. J. Hum. Genet. 2003, 73:1240-1249.
3. Boon L.M., Mulliken J.B., Vikkula M. RASA1: variable phenotype with capillary and arteriovenous malformations. Curr. Opin. Genet. Dev. 2005, 15:265-269.
4. Hershkovitz D., Bercovich D., Sprecher E., Lapidot M. RASA1 mutations may cause hereditary capillary malformations without arteriovenous malformations. Br. J. Dermatol. 2008, 158:1035-1040.
5. Thiex R., Mulliken J.B., Revencu N., Boon L.M., Burrows P.E., Cordisco M., Dwight Y., Smith E.R., Vikkula M., Orbach D.B. A novel association between RASA1 mutations and spinal arteriovenous anomalies. AJNR Am. J. Neuroradiol. 2010, 31:775-779.
6. Bayrak Toydemir P., Stevenson D. RASA1 related disorders. GeneReviews 2011, University of Washington, Seattle. http://www.ncbi.nlm.nih.gov/books/NBK52764/, R.A. Pagon, T.D. Bird, C.R. Dolan, K. Stephens (Eds.).
7. Tidyman W.E., Rauen K.A. The RASopathies: developmental syndromes of Ras/MAPK pathway dysregulation. Curr. Opin. Genet. Dev. 2009, 19:230-236.
8. Carr C.W., Zimmerman H.H., Martin C.L., Vikkula M., Byrd A.C., Abdul-Rahman O.A. 5q14.3 neurocutaneous syndrome: a novel contiguous gene syndrome caused by simultaneous deletion of RASA1 and MEF2C. Am. J. Med. Genet. A 2011, 155:1640-1645.
9. Wang J., Ruan K. miR-335 is involved in the rat epididymal development by targeting the mRNA of RASA1. Biochem. Biophys. Res. Commun. 2010, 402:222-227.